BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8150784)

  • 41. [Breast cancer, model in biological and clinical oncology. Role of hormones and growth factors].
    Saez S; Martin PM
    Arch Anat Cytol Pathol; 1995; 43(1-2):12-8. PubMed ID: 7794022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Local growth factors for breast cancer: general review and potential value for clinician].
    Piccart MJ; Devleeschouwer N; Leclercq G; L'Hermite M
    Bull Cancer; 1991; 78(3):215-27. PubMed ID: 1647237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biomarkers in tongue cancer: understanding the molecular basis and their clinical implications.
    Zheng M; Li L; Tang YL; Liang XH
    Postgrad Med J; 2010 May; 86(1015):292-8. PubMed ID: 20392934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biologic indicators of exposure: are markers associated with oncogenesis useful as biologic markers of effect?
    Ziegler BL; Weiss M; Thoma S; Lamping C; Fliedner TM
    Stem Cells; 1995 May; 13 Suppl 1():326-38. PubMed ID: 7488965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Modern prospects for molecular-biochemical methods for evaluating biological "behavior" of breast neoplasms].
    Kushlinskiĭ NE; Gershteĭn ES
    Vestn Ross Akad Med Nauk; 2001; (9):65-70. PubMed ID: 11676260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biology of breast cancer and its clinical implications.
    Davidson NE
    Curr Opin Oncol; 1989 Dec; 1(2):269-76. PubMed ID: 2562285
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical relevance of breast cancer biology.
    Oza AM; Tannock IF
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):1-14. PubMed ID: 7512087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autocrine and paracrine growth regulation of breast cancer: clinical implications.
    Osborne CK; Arteaga CL
    Breast Cancer Res Treat; 1990 Jan; 15(1):3-11. PubMed ID: 2183891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenes and tumor growth factors in breast cancer. A minireview.
    Ernberg IT
    Acta Oncol; 1990; 29(3):331-4. PubMed ID: 2194533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent translational research: computational studies of breast cancer.
    Retsky M; Demicheli R; Hrushesky W; Speer J; Swartzendruber D; Wardwell R
    Breast Cancer Res; 2005; 7(1):37-40. PubMed ID: 15642181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The biology of breast cancer.
    Hoskins K; Weber BL
    Curr Opin Oncol; 1994 Nov; 6(6):554-9. PubMed ID: 7827164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Special conference on 'growth factors, development and cancer.
    Broggini M
    Ann Oncol; 1994 Sep; 5(7):575-7. PubMed ID: 7993830
    [No Abstract]   [Full Text] [Related]  

  • 53. Significance of immunohistochemistry in breast cancer.
    Zaha DC
    World J Clin Oncol; 2014 Aug; 5(3):382-92. PubMed ID: 25114853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Organ Specific Tumor Markers: What's New?
    Vaidyanathan K; Vasudevan DM
    Indian J Clin Biochem; 2012 Apr; 27(2):110-20. PubMed ID: 23542399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 codon 72 polymorphism and breast cancer risk: A meta-analysis.
    Hou J; Jiang Y; Tang W; Jia S
    Exp Ther Med; 2013 May; 5(5):1397-1402. PubMed ID: 23737888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis.
    Saleh F; Abdeen S
    J Carcinog; 2007 Sep; 6():12. PubMed ID: 17892570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and characterization of new mammary adenocarcinoma cell lines derived from double transgenic mice expressing GFP and neu oncogene.
    Sacco MG; Faggioli F; Soldati S; Gribaldo L; Collotta A; Pariselli F; Malerba I; Musio A; Montagna C; Catò EM; Vezzoni P
    Cell Prolif; 2006 Dec; 39(6):611-22. PubMed ID: 17109643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rb localization and phosphorylation kinetics correlate with the cellular phenotype of cultured breast adenocarcinoma cells.
    Botos J; Barhoumi R; Burghardt R; Kochevar DT
    In Vitro Cell Dev Biol Anim; 2002 Apr; 38(4):235-41. PubMed ID: 12197776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells.
    Houghton RL; Dillon DC; Molesh DA; Zehentner BK; Xu J; Jiang J; Schmidt C; Frudakis A; Repasky E; Maltez Filho A; Nolasco M; Badaro R; Zhang X; Roche PC; Persing DH; Reed SG
    Mol Diagn; 2001 Jun; 6(2):79-91. PubMed ID: 11468693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Ribonuclease A and Deoxyribonuclease I on Immunostaining of Ki-67 in Cultured Melanoma Cells.
    Benfares J; Tourneau AL; Audouin J; Szekeres G
    Pathol Oncol Res; 1996; 2(1-2):63-65. PubMed ID: 11173587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.